Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
For gastric conditions (ulcers, gastritis, mucosal erosion), administering on an empty stomach or 30 minutes before meals maximizes contact with the gastric lining
TB-500 provides critical enhancement of cellular migration and epithelial coverage that drives wound closure, with research demonstrating that topical or intraperitoneal TB-500 administration increases reepithelialization by 42% over controls at 4 days post-wounding and 61% at 7 days, with treated wounds showing enhanced contraction (at least 11% more than controls by day 7) and superior architectural organization
The only trial FDA staff were able to find about the effectiveness of using BPC-157 to treat ulcerative colitis was a meeting abstract reporting on the results of a study using 46 people in which the peptide was given as an enema, not as an injection
Kongsgaard et al., Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy, Scandinavian journal of medicine & science in sports 19, no
Craig Koniver found many benefits of using BPC-157 in his clinic before it was removed by the FDA, confirming the above hypotheses that it is an anti-inflammatory and tissue healer
